InsiderClue
← All stocks

Medpace Holdings, Inc.

MEDP Net selling
CIK 0001668397 #724 in the set updated 17 Sep 2026
Bought (120 mo)
$309.19M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.60B
$288.08M on a plan · $135.21M straight out of an exercise
Sold at will
$3.18B
431 of 500 sales
Net
−$3.30B
−$2.87B against sales at will

By person

16 insiders · 603 transactions
6,620×

August J. Troendle holds 6,620 times base salary in stock. $6.21B of shares against $937.42K in salary for 2025.

Salary from the company's own proxy. The shares are what August J. Troendle last reported holding, valued at $620.27, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Troendle August J.
President & CEO
$154.56M (17)
$1.38B (230)
−$1.23B
10,005,932
35.85%
$6.21B
−34.0%
Medpace Limited Partnership entity
10% owner
—
$998.48M (6)
−$998.48M
0
0.0000%
$0.00
−100.0%
Medpace Investors, LLC entity
10% owner
$154.56M (17)
$999.64M (179)
−$845.08M
4,733,019
16.96%
$2.94B
−48.6%
GEIGER JESSE J
President
—
$83.46M (22) scheduled
−$83.46M
15,000
0.0537%
$9.30M
—
BURWIG SUSAN E
Exec. VP, Operations
—
$61.14M (17)
−$61.14M
62,984
0.2257%
$39.07M
+227.9%
EWALD STEPHEN P
General Counsel & Corp. Secy.
$652.22 (1)
$33.36M (15) scheduled
−$33.36M
20,343
0.0729%
$12.62M
—
Kraft Robert O.
Director
—
$15.18M (6) scheduled
−$15.18M
955
0.0034%
$592.36K
—
Brady Kevin M.
CFO & Treasurer
—
$11.87M (7) scheduled
−$11.87M
12,830
0.0460%
$7.96M
+156.6%
DAVENPORT FRED B JR
Director
$72.90K (1)
$8.41M (3) scheduled
−$8.33M
5,798
0.0208%
$3.60M
+286.5%
Carley Brian T
Director
—
$4.43M (2)
−$4.43M
27,825
0.0997%
$17.26M
—
McCarthy Cornelius P. III
Director
—
$1.93M (3)
−$1.93M
12,275
0.0440%
$7.61M
—
Keating Ashley M.
Director
—
$1.69M (8) scheduled
−$1.69M
250
0.0009%
$155.07K
—
King Tom C
Director
—
$79.60K (2) scheduled
−$79.60K
598
0.0021%
$370.92K
—
Brown Bruce
Director
—
—
—
9,295
0.0333%
$5.77M
—
BUCKNELL PENELOPE J
VP, Human Resources
—
—
—
3,000
0.0107%
$1.86M
—
Fifth Cinven Fund (No. 1) Limited Partnership entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

36
Insider
Date
Role
Action
Shares
Price
Amount
EWALD STEPHEN P
27 Feb 2025
General Counsel & Corp. Secy.
Buy
2
$326.11
$652.22
Troendle August J.
22 Sep 2022
CEO
Buy indirect
57,426
$154.59
$8.88M
Medpace Investors, LLC
22 Sep 2022
10% owner
Buy
57,426
$154.59
$8.88M
Medpace Investors, LLC
21 Sep 2022
10% owner
Buy
94,119
$161.63
$15.21M
Troendle August J.
21 Sep 2022
CEO
Buy indirect
94,119
$161.63
$15.21M
Medpace Investors, LLC
20 Sep 2022
10% owner
Buy
94,119
$155.14
$14.60M
Troendle August J.
20 Sep 2022
CEO
Buy indirect
94,119
$155.14
$14.60M
Troendle August J.
19 Sep 2022
CEO
Buy indirect
94,119
$153.48
$14.45M
Medpace Investors, LLC
19 Sep 2022
10% owner
Buy
94,119
$153.48
$14.45M
Troendle August J.
16 Sep 2022
CEO
Buy indirect
62,516
$149.58
$9.35M
Medpace Investors, LLC
16 Sep 2022
10% owner
Buy
62,516
$149.58
$9.35M
Medpace Investors, LLC
15 Sep 2022
10% owner
Buy
62,516
$153.11
$9.57M
Troendle August J.
15 Sep 2022
CEO
Buy indirect
62,516
$153.11
$9.57M
Medpace Investors, LLC
14 Sep 2022
10% owner
Buy
62,516
$152.66
$9.54M
Troendle August J.
14 Sep 2022
CEO
Buy indirect
62,516
$152.66
$9.54M
Medpace Investors, LLC
13 Sep 2022
10% owner
Buy
62,516
$157.12
$9.82M
Troendle August J.
13 Sep 2022
CEO
Buy indirect
62,516
$157.12
$9.82M
Medpace Investors, LLC
12 Sep 2022
10% owner
Buy
62,515
$167.58
$10.48M
Troendle August J.
12 Sep 2022
CEO
Buy indirect
62,515
$167.58
$10.48M
Medpace Investors, LLC
9 Sep 2022
10% owner
Buy
56,557
$164.33
$9.29M
Troendle August J.
9 Sep 2022
CEO
Buy indirect
56,557
$164.33
$9.29M
Medpace Investors, LLC
8 Sep 2022
10% owner
Buy
56,557
$157.65
$8.92M
Troendle August J.
8 Sep 2022
CEO
Buy indirect
56,557
$157.65
$8.92M
Troendle August J.
7 Sep 2022
CEO
Buy indirect
56,557
$150.72
$8.52M
Medpace Investors, LLC
7 Sep 2022
10% owner
Buy
56,557
$150.72
$8.52M
Troendle August J.
6 Sep 2022
CEO
Buy indirect
56,557
$147.59
$8.35M
Medpace Investors, LLC
6 Sep 2022
10% owner
Buy
56,557
$147.59
$8.35M
Troendle August J.
2 Sep 2022
CEO
Buy indirect
48,714
$144.98
$7.06M
Medpace Investors, LLC
2 Sep 2022
10% owner
Buy
48,714
$144.98
$7.06M
Troendle August J.
1 Sep 2022
CEO
Buy indirect
42,076
$144.52
$6.08M
Medpace Investors, LLC
1 Sep 2022
10% owner
Buy
42,076
$144.52
$6.08M
Medpace Investors, LLC
18 Jul 2022
10% owner
Buy
8,330
$145.00
$1.21M
Troendle August J.
18 Jul 2022
CEO
Buy indirect
8,330
$145.00
$1.21M
Medpace Investors, LLC
14 Jul 2022
10% owner
Buy
22,290
$144.59
$3.22M
Troendle August J.
14 Jul 2022
CEO
Buy indirect
22,290
$144.59
$3.22M
DAVENPORT FRED B JR
17 Feb 2022
Director
Buy indirect
500
$145.80
$72.90K
Showing 250 of 603 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 521
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 52
Sales at will 431
Transactions with no price 0
Shares from compensation/vesting 26,761,827
Sales filed before the plan box existed 311
History held since 3 Nov 2016